Patent directory · USPTO A61K / A61P
Patents matching “IMMUNE DESIGN CORP.”
17 pharma patents match "IMMUNE DESIGN CORP." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 17 pharmaceutical patents matching "IMMUNE DESIGN CORP." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11365230
Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof
granted -
US 11135283
Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids
granted -
US 10993999
Materials and methods for producing improved lentiviral vector particles
granted -
US 10993956
GLA monotherapy for use in cancer treatment
granted -
US 10584356
Multigenome retroviral vector preparations and methods and systems for producing and using same
granted -
US 10391157
Materials and methods for producing improved lentiviral vector particles
granted -
US 10391164
Vaccines for HSV-2
granted -
US 10342815
GLA monotherapy for use in cancer treatment
granted -
US 10179919
Multigenome retroviral vector preparations and methods and systems for producing and using same
granted -
US 9895435
Vaccines for HSV-2
granted -
US 9713635
Materials and methods for producing improved lentiviral vector particles
granted -
US 9555099
Vaccines for HSV-2
granted -
US 9044420
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
granted -
US 8962593
GLA monotherapy for use in cancer treatment
granted -
US 8957047
GLA monotherapy for use in cancer treatment
granted -
US 8323662
Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein
granted -
US 8187872
Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein
granted